ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has completed its acquisition of Harvest Medicine Inc. pursuant to the terms of a share purchase agreement dated January 31, 2018. Per the update, the acquisition was completed in consideration for, among other things, a cash payment of $1.5 million, the issuance of 1,056,338 common shares in the capital of the company and additional post-closing consideration related to certain performance milestones, including patient revenue and profitability metrics. Moving forward, Harvest Medicine will operate as a wholly-owned subsidiary of ABcann, but it will maintain its commitment to being an open platform that enables patients to register with the licensed producers of their choice. “The acquisition of Harvest Medicine represents further progress toward our goal of becoming a vertically integrated medical cannabis company,” Barry Fishman, CEO of ABcann, stated in the news release. “It is one of the fastest-growing medical cannabis clinics in Canada, with an aggressive expansion plan and a patient-focused approach that is aligned with ABcann’s philosophy of quality and innovation.”
To view the full press release, visit http://cnw.fm/GKm5N
About ABcann Global Corp.
ABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centered on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products. The company is expanding its cultivation capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel. For more information, visit www.ABcannGlobal.com
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com